SANCUSO: payments to doctors
Payments that named SANCUSO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $798K
- Providers
- 2,064
- Transactions
- 3,657
- Average per transaction
- $218
The per-transaction average — $218 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,064 providers the average total is $387, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Cumberland Pharmaceuticals, Inc. | $597,627 | 74.9% |
| Kyowa Kirin, Inc. | $193,663 | 24.3% |
| Kyowa Kirin Services Ltd | $6,500 | 0.8% |
| Verity Pharmaceuticals Inc. | $483 | 0.1% |